CMG Pharmaceutical Co. Ltd (058820) — Cash Flow Reinvestment Rate
CMG Pharmaceutical Co. Ltd (058820) has a Cash Flow Reinvestment Rate of 113.83x as of December 2024, reinvesting ₩33.02 Billion (capex ₩31.75 Billion plus investments ₩1.27 Billion) from operating cash flow of ₩290.09 Million. Explore capital reinvestment ratio of CMG Pharmaceutical Co. Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
CMG Pharmaceutical Co. Ltd Cash Flow Reinvestment Rate (2014–2024)
Historical reinvestment intensity for CMG Pharmaceutical Co. Ltd across 11 annual periods. Also explore CMG Pharmaceutical Co. Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for CMG Pharmaceutical Co. Ltd (2014–2024)
Year-by-year capital reinvestment analysis for CMG Pharmaceutical Co. Ltd. For live market cap and broader valuation context, see CMG Pharmaceutical Co. Ltd (058820) market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (KRW) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 301.60x | ₩87.49 Billion | ₩290.09 Million | ₩31.75 Billion | ▲ +2612.3% |
| 2023 | 11.12x | ₩43.47 Billion | ₩3.91 Billion | ₩15.25 Billion | ▲ +159.3% |
| 2022 | 4.29x | ₩21.18 Billion | ₩4.94 Billion | ₩10.31 Billion | ▲ +94.2% |
| 2021 | 2.21x | ₩12.43 Billion | ₩5.63 Billion | ₩3.95 Billion | ▼ -71.3% |
| 2020 | 7.70x | ₩22.66 Billion | ₩2.94 Billion | ₩9.65 Billion | ▼ -67.6% |
| 2019 | 23.77x | ₩67.12 Billion | ₩2.82 Billion | ₩8.18 Billion | ▲ +41.5% |
| 2018 | 16.81x | ₩14.90 Billion | ₩886.78 Million | ₩2.55 Billion | ▲ +1871.7% |
| 2017 | 0.85x | ₩1.66 Billion | ₩1.95 Billion | ₩760.59 Million | ▼ -96.3% |
| 2016 | 23.34x | ₩53.90 Billion | ₩2.31 Billion | ₩799.00 Million | ▲ +551.8% |
| 2015 | 3.58x | ₩8.64 Billion | ₩2.41 Billion | ₩3.64 Billion | ▼ -72.5% |
| 2014 | 13.02x | ₩9.44 Billion | ₩724.89 Million | ₩9.42 Billion | — |